Bio-Combination 4 (Rxhomeo Private Limited d.b.a. Rxhomeo, Inc)


Welcome to the PulseAid listing for the Bio-Combination 4 drug offered from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
NON-PROPRIETARY NAME: CALCAREA FLUORICA, KALI MURIATICUM, NATRUM MURIATICUM, SILICEA
SUBSTANCE NAME: CALCIUM FLUORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SILICON DIOXIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2016-04-11
END MARKETING DATE: 0000-00-00


Bio-Combination 4 HUMAN OTC DRUG Details:

Item DescriptionBio-Combination 4 from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
LABELER NAME: Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 3; 3; 6; 12([hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1)
START MARKETING DATE: 2016-04-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 15631-2359_e5ea271c-fadd-490a-b59c-7f450e336996
PRODUCT NDC: 15631-2359
APPLICATION NUMBER:

Other CALCIUM FLUORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SILICON DIOXIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Rxhomeo Private Limited d.b.a. Rxhomeo, IncBio-Combination 4